Laurion Capital Management LP Sage Therapeutics, Inc. Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$70.65 - $96.76 $1.22 Million - $1.67 Million	-17,240 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$58.41 - $89.06 $1.01 Million - $1.54 Million	17,240 New	17,240 $1.49 Million
Q2 2020 Aug 14, 2020	SELL	$25.95 - $43.15 $877,110 - $1.46 Million	-33,800 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$26.15 - $77.24 $883,870 - $2.61 Million	33,800 New	33,800 $971,000
Q1 2018 May 14, 2018	SELL	$152.15 - $192.33 $5.33 Million - $6.74 Million	-35,052 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$60.72 - $167.34 $2.13 Million - $5.87 Million	35,052	35,052 $5.77 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.